Eye­Point Phar­ma­ceu­ti­cals is sell­ing $100 mil­lion worth of shares on the back of pos­i­tive mid-stage da­ta for a drug-de­vice can­di­date in di­a­bet­ic mac­u­lar ede­ma.

EyePoint's Investigational Drug Shows Early And Sustained Improvement Than Regeneron's Eylea For Diabetes-Associated Vision Loss Vandana Singh Mon, Oct 28, 2024, 12:16 PM 2 min read ...

THE Zimbabwe Civil Liberties and Drug Network (ZCLDN) has warned of the dangers of badmouthing persons with substance use disorder as this militates against the fight against drug and substance abuse.

While the Serpent is a formidable opponent and the cause of much stress when venturing into the Skull Cavern, this is one of their many great drops, and a fairly common one. A Stardew Valley ...

Michael K. Jensen, B.S.Pharm., M.S., is Clinical Associate Professor of Pharmacy Practice, College of Pharmacy, University of Utah, Salt Lake City, and Clinical ...

A new study found that artificial expiration dates for eye drops can lead to significant medication, plastic, and cost wastage. The investigators recommended establishing practices that use ophthalmic ...

Vitamins and supplements can help you fill in the gaps in your diet while strengthening your vision and staving off eye diseases. Read on to learn the best vitamins and supplements for eye health ...

How do you get Black Ops 6 Twitch drops? We love chilling out watching others game when we’ve had our fill of being behind the keyboard for the day. Twitch drops make supporting our favorite ...

But a generic version (and the active ingredient ... you may be at risk of experiencing a dangerous drop in blood pressure. Severe drops in blood pressure can also result in less oxygen moving ...

As someone with relatively normal under-eyes, I’ve never had much use for eye creams, even though they’ve always been touted as a must-have for anyone who was serious about their multistep ...

Noting that eye drops in ophthalmology clinics have artificial expiration dates of 14 and 28 days, John M. Tan, from the New York Eye and Ear Infirmary of Mount Sinai in New York City, and ...

Regeneron Pharmaceutical (NASDAQ:REGN) fell 2% after a court rejected its request for a temporary injunction blocking sales of its generic Eylea by Amgen (AMGN). Amgen ticked higher by 0.4%.